Artelo Biosciences Stock (NASDAQ: ARTL) stock price, news, charts, stock research, profile.
Open | - |
Close | - |
Volume / Avg. | 1.00 / 79.18K |
Day Range | - - - |
52 Wk Range | 1.00 - 1.78 |
Market Cap | $3.55M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 40 |
Short Interest | 1.43% |
Days to Cover | 5.64 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Artelo Biosciences (NASDAQ:ARTL) through any online brokerage.
Other companies in Artelo Biosciences’s space includes: NovaBay Pharmaceuticals (AMEX:NBY), Processa Pharma (NASDAQ:PCSA), Titan Pharma (NASDAQ:TTNP), cbdMD (AMEX:YCBD) and 60 Degrees (NASDAQ:SXTP).
Artelo Biosciences has a consensus price target of $32.50.
The stock price for Artelo Biosciences (NASDAQ: ARTL) is $1.1 last updated September 18, 2024 at 7:20 PM EDT.
There are no upcoming dividends for Artelo Biosciences.
Artelo Biosciences’s Q3 earnings are confirmed for Monday, November 11, 2024.
There is no upcoming split for Artelo Biosciences.
Artelo Biosciences is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.